Skip to content

Advertisement

BMC Infectious Diseases

Hepatitis and co-infections

Section edited by Jean-Claude Desenclos

This section aims to publish studies looking at all aspects of the prevention, diagnosis and management of hepatitis in humans as well as related molecular genetics, pathophysiology, and epidemiology

Previous Page Page 1 of 7 Next Page
  1. Content type: Research article

    Increasing the proportion diagnosed with and on treatment for chronic hepatitis C (CHC) is key to the elimination of hepatitis C in Europe. This study contributes to secondary prevention planning in the Europe...

    Authors: A. M. Falla, A. A. Ahmad, E. Duffell, T. Noori and I. K. Veldhuijzen

    Citation: BMC Infectious Diseases 2018 18:42

    Published on:

  2. Content type: Research article

    Chronic hepatitis B (CHB) related morbidity and mortality can be reduced through risk group screening, linkage to care and anti-viral treatment. This study estimates the number of CHB cases among foreign-born ...

    Authors: Amena A. Ahmad, Abby M. Falla, Erika Duffell, Teymur Noori, Angela Bechini, Ralf Reintjes and Irene K. Veldhuijzen

    Citation: BMC Infectious Diseases 2018 18:34

    Published on:

  3. Content type: Research article

    The overall prevalence of hepatitis B virus (HBV) infection in China is declining. The purpose of this study was to use a community-based epidemiological study to update the infection status of hepatitis B vir...

    Authors: Ping Chen, Qinfen Xie, Ting Chen, Jiawei Wu, Jie Wu, Bing Ruan, Zhiqin Zhang, Hainv Gao and Lanjuan Li

    Citation: BMC Infectious Diseases 2017 17:809

    Published on:

  4. Content type: Research article

    The last decade was marked by major advances in HCV treatment with the introduction of first wave protease inhibitors (1st-wave PIs, telaprevir or boceprevir) in 2011 and second direct-acting antivirals (2nd-w...

    Authors: Cécile Brouard, Marjorie Boussac-Zarebska, Christine Silvain, Julien Durand, Victor de Lédinghen, Josiane Pillonel and Elisabeth Delarocque-Astagneau

    Citation: BMC Infectious Diseases 2017 17:784

    Published on:

  5. Content type: Research article

    Hepatitis B vaccination for healthcare workers (HCWs) is a key component of the WHO Hepatitis B Elimination Strategy 2016–2021. Data on current hepatitis B vaccine coverage among health care workers in Sub-Sah...

    Authors: Dotto Aaron, Tumaini J. Nagu, John Rwegasha and Ewaldo Komba

    Citation: BMC Infectious Diseases 2017 17:786

    Published on:

  6. Content type: Research article

    Prospective studies have shown that 80% of acute hepatitis C virus (HCV) cases progress to chronic infection; approximately 10-20% of patients with these conditions will develop liver cirrhosis within 2 to 3 d...

    Authors: Caroline Manchiero, Arielle Karen da Silva Nunes, Mariana Carvalheiro Magri, Bianca Peixoto Dantas, Celso Carmo Mazza, Antonio Alci Barone and Fátima Mitiko Tengan

    Citation: BMC Infectious Diseases 2017 17:780

    Published on:

  7. Content type: Research article

    There are few data available on the prevalence, incidence, and residual risk of transfusion-transmitted HBV (TT-HBV) infections among Chinese blood donors. This study investigated the demographic characteristi...

    Authors: Ling Li, Tingting Han, Liang Zang, Libin Niu, Weifang Cheng, Hongkeng Lin, Ka Yi Li, Ruan Cao, Binghai Zhao, Yuqiang Liu, Guojin Ou, Xiao Liu, Yingjie Qi, Yanhua Li and Zhong Liu

    Citation: BMC Infectious Diseases 2017 17:754

    Published on:

  8. Content type: Research article

    Direct acting antivirals are expected to drastically reduce the burden of hepatitis C virus (HCV) in people living with Human Immunodeficiency Virus (HIV). However, rates of HCV testing, re-testing and inciden...

    Authors: David C. Boettiger, Matthew G. Law, Gregory J. Dore, Rebecca Guy, Denton Callander, Basil Donovan, Catherine C. O’Connor, Christopher K. Fairley, Margaret Hellard and Gail Matthews

    Citation: BMC Infectious Diseases 2017 17:740

    Published on:

  9. Content type: Research article

    Six distinct genetic variants (genotypes 1 − 6) of hepatitis C virus (HCV) exist globally. Certain genotypes are more prevalent in particular countries or regions than in others but, globally, genotype 3 (GT3)...

    Authors: Hosnieh Fathi, Andrew Clark, Nathan R. Hill and Geoffrey Dusheiko

    Citation: BMC Infectious Diseases 2017 17:722

    Published on:

  10. Content type: Research article

    Non-structural 5A protein (NS5A) resistance-associated substitutions (RASs) have been identified in patients infected with hepatitis C virus (HCV), even prior to exposure to direct-acting antiviral agents (DAA...

    Authors: Fernanda Malta, Karine Vieira Gaspareto, Gaspar Lisboa-Neto, Flair José Carrilho, Maria Cássia Mendes-Correa and João Renato Rebello Pinho

    Citation: BMC Infectious Diseases 2017 17:716

    Published on:

  11. Content type: Research article

    Schistosoma mansoni and Hepatitis C virus (HCV) are co-existence in sub-Saharan Africa and co-infection is common among humans population. The immunological responses characterized wit...

    Authors: Humphrey D. Mazigo, Stella Kepha, Godfrey M. Kaatano and Safari M. Kinung’hi

    Citation: BMC Infectious Diseases 2017 17:668

    Published on:

  12. Content type: Research article

    Hepatitis B Virus (HBV) infection is a worldwide public health problem. In Nepal, the prevalence of HBV is found to be low (0.9%), although high prevalence (≥8%) of HBV infection is depicted among subgroup/pop...

    Authors: Purusotam Raj Shedain, Madhu Dixit Devkota, Megha Raj Banjara, Huang Ling and Subash Dhital

    Citation: BMC Infectious Diseases 2017 17:667

    Published on:

  13. Content type: Research article

    For hepatitis B patients who do not meet the treatment criteria recommended by guidelines, therapy decisions depend on hepatic histology. Angiopoietin-like protein 2 (Angptl2) is a mediator of chronic inflamma...

    Authors: Yongqiong Deng, Hong Zhao, Jiyuan Zhou, Linlin Yan and Guiqiang Wang

    Citation: BMC Infectious Diseases 2017 17:650

    Published on:

  14. Content type: Research article

    Hepatitis B virus (HBV) affects people worldwide but the local burden especially in pregnant women and their new born babies is unknown. In Rwanda HIV-infected individuals who are also infected with HBV are su...

    Authors: Mwumvaneza Mutagoma, Helene Balisanga, Samuel S. Malamba, Dieudonné Sebuhoro, Eric Remera, David J. Riedel, Steve Kanters and Sabin Nsanzimana

    Citation: BMC Infectious Diseases 2017 17:618

    Published on:

  15. Content type: Research article

    Hepatitis B virus (HBV) infection is a major public health problem globally. HBV genotypes and subgenotypes influence disease transmission, progression, and treatment outcome. A study was conducted among treat...

    Authors: Thi Ton Taht Bui, Tan Thanh Tran, My Ngoc Nghiem, Pierre Rahman, Thi Thanh Thanh Tran, Man Nguyen Huy Dinh, Manh Hung Le, Van Vinh Chau Nguyen, Guy Thwaites and Motiur Rahman

    Citation: BMC Infectious Diseases 2017 17:601

    Published on:

  16. Content type: Research article

    Hepatitis B virus (HBV) infection is a major cause of chronic liver disease worldwide. In immunocompromised patients, the chronicity rates of HBV infection are higher, but the rates of hepatitis Be antigen (HB...

    Authors: Fatima Mitiko Tengan, Edson Abdala, Marisa Nascimento, Wanderley Marques Bernardo and Antonio Alci Barone

    Citation: BMC Infectious Diseases 2017 17:587

    Published on:

  17. Content type: Case report

    HBV reactivation is associated with high mortality rates in hematopoietic stem cell transplantation (HSCT) and prophylactic lamivudine (LMV) treatment is suggested to prevent this phenomenon. However, the dura...

    Authors: C. Cerva, G. Maffongelli, V. Svicher, R. Salpini, L. Colagrossi, A. Battisti, B. Mariotti, R. Cerretti, L. Cudillo and L. Sarmati

    Citation: BMC Infectious Diseases 2017 17:566

    Published on:

  18. Content type: Research article

    Hepatitis A virus (HAV) is a food and water-borne virus causing clinical (mainly hepatitis) and subclinical disease in humans. It is important to characterize circulating strains of HAV in order to prevent HAV...

    Authors: Huseyin Yilmaz, Asiye Karakullukcu, Nuri Turan, Utku Y. Cizmecigil, Aysun Yilmaz, Ayse A. Ozkul, Ozge Aydin, Alper Gunduz, Mahmut Mete, Fadile Y. Zeyrek, Taner T. Kirazoglu, Juergen A. Richt and Bekir Kocazeybek

    Citation: BMC Infectious Diseases 2017 17:561

    Published on:

  19. Content type: Research article

    Data on the cost effectiveness of hepatitis B virus (HBV) screening and vaccination strategies for prevention of vertical transmission of HBV in resource limited settings is sparse.

    Authors: Angela Devine, Rebecca Harvey, Aung Myat Min, Mary Ellen T. Gilder, Moo Koh Paw, Joy Kang, Isabella Watts, Borimas Hanboonkunupakarn, François Nosten and Rose McGready

    Citation: BMC Infectious Diseases 2017 17:552

    Published on:

  20. Content type: Research article

    Extensively Drug-Resistant (XDR) Tuberculosis (TB) has posed a great threat to global health and finance systems, especially for developing countries with high TB and Multidrug-Resistant (MDR) TB burden.

    Authors: Xiao-chun He, Ning-ning Tao, Yao Liu, Xian-xin Zhang and Huai-chen Li

    Citation: BMC Infectious Diseases 2017 17:555

    Published on:

Previous Page Page 1 of 7 Next Page

2016 Journal Metrics

Advertisement